As of 2025-07-05, the EV/EBITDA ratio of Paratek Pharmaceuticals Inc (PRTK) is -7.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTK's latest enterprise value is 343.47 mil USD. PRTK's TTM EBITDA according to its financial statements is -44.39 mil USD. Dividing these 2 quantities gives us the above PRTK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 10.3x | 8.1x |
| Forward P/E multiples | 10.8x - 14.3x | 12.1x |
| Fair Price | (12.09) - (11.72) | (11.58) |
| Upside | -642.3% - -625.7% | -619.4% |
| Date | EV/EBITDA |